The short answer is: probably, but science hasn’t proven it definitively. In 2024, a panel of 29 international experts convened by the World Health Organization’s cancer research agency (IARC) classified talc as “probably carcinogenic to humans,” based largely on its association with ovarian cancer. That’s the second-highest category on a four-tier scale, one step below “confirmed carcinogen.” The evidence consistently points toward a real risk, but key uncertainties remain about how large that risk is and whether talc itself or contaminants like asbestos deserve the blame.
What the Studies Actually Show
Dozens of studies over several decades have examined whether women who apply talcum powder to the genital area develop ovarian cancer at higher rates. A 2022 meta-analysis pooling the strongest available data found that frequent perineal talc use was associated with a 47% increase in ovarian cancer odds. That number held up across multiple sensitivity checks, barely budging when weaker studies were removed from the analysis.
That sounds alarming, but context matters. Ovarian cancer is relatively rare to begin with. The lifetime risk for the average woman is roughly 1.1%. A 47% relative increase would bring that to about 1.6%. So for any individual woman, the absolute increase in risk is small, even if the association is real.
Why Scientists Still Aren’t Certain
The biggest problem is a split between two types of studies. Case-control studies, which ask women already diagnosed with ovarian cancer to recall their past powder use, consistently find an increased risk. Prospective cohort studies, which track healthy women forward in time and record their habits before any diagnosis, consistently find no meaningful association. One large review found a pooled odds ratio of 1.35 in case-control studies but just 1.06 in cohort studies, a difference that is statistically important.
This gap raises a specific concern called recall bias. Women who have been diagnosed with cancer tend to search their memory more thoroughly for possible causes. A woman with ovarian cancer may be more likely to remember and report past talc use than a healthy woman filling out a routine survey. That bias alone could inflate the apparent risk in case-control studies.
The IARC working group acknowledged this directly, noting that “biases in how talc use was reported in the epidemiological studies could not be ruled out with reasonable confidence.” It’s one of the main reasons they stopped at “probably” rather than “confirmed.”
The Asbestos Complication
Talc and asbestos are minerals that form in the same geological deposits, and historically, talc products were sometimes contaminated with asbestos fibers. Asbestos is a confirmed carcinogen. In tissue analysis of ovarian tumors removed from ten talc users, researchers detected asbestos in samples from eight of them and fibrous talc in all ten.
This creates a chicken-or-egg problem for researchers. Most of the women in the older epidemiological studies used talc products manufactured decades ago, when contamination standards were far less rigorous. The IARC panel noted that asbestos contamination “could not be excluded in most of the studies of exposed humans.” So it remains unclear whether pure talc is the culprit, whether trace asbestos is doing the damage, or whether both contribute.
The FDA has tested cosmetic talc products periodically since 2009. An initial survey in 2009-2010 found no asbestos in any samples of cosmetic-grade talc. However, by 2019, the agency issued a safety alert warning consumers away from certain products that had tested positive for asbestos, and testing has continued annually through at least 2023. Modern cosmetic-grade talc is generally considered asbestos-free, but enforcement relies on manufacturer compliance and periodic spot checks rather than mandatory pre-market testing of every batch.
How Talc Could Reach the Ovaries
For talc to cause ovarian cancer, the particles would need to physically travel from the skin’s surface to the ovaries. Research confirms this happens. In a study of five women who had used perineal talc and later developed ovarian cancer, researchers found talc particles in multiple pelvic locations: lymph nodes, the cervix, the uterus, fallopian tubes, and ovaries. Some women had talc in four separate sites distant from where the powder was originally applied.
The particles appear to travel through two routes. The first is direct ascent through the reproductive tract, from the vagina through the uterus and fallopian tubes to the ovarian surface. The second, and possibly more important, route is the lymphatic system. Talc particles are typically 1 to 10 micrometers in size, small enough to slip into lymphatic channels that sit just beneath the skin’s surface. Once inside the lymphatic network, the particles are carried by the system’s natural pumping action toward pelvic lymph nodes and eventually to the ovaries.
No Clear Dose-Response Pattern
If talc truly causes cancer, you’d expect heavier use to carry more risk. The evidence on this point is surprisingly weak. Studies have looked at both how many years women used talc and how often they applied it per month. Neither measure shows a consistent, statistically significant trend of increasing risk with increasing exposure. One study found a borderline association with longer duration of use (about 9% increased risk per decade of exposure), but frequency of application showed no significant link at all.
Interestingly, some data suggest that shorter durations and lower frequencies of use showed the strongest risk elevations, which is the opposite of what a straightforward dose-response relationship would predict. This pattern is difficult to explain biologically and adds to the uncertainty about whether the association is causal.
Cornstarch as an Alternative
Cornstarch-based body powders are the most common alternative to talc. Cornstarch is an entirely different substance: an organic plant-derived carbohydrate rather than a mined mineral. It carries no risk of asbestos contamination and has a fundamentally different chemical structure. A review of the available evidence concluded that perineal application of cornstarch powder is not predicted to be a risk factor for ovarian cancer. For anyone looking to avoid the uncertainty around talc, cornstarch powder is a straightforward swap.
What This Means in Practical Terms
The evidence is strong enough to take seriously but not strong enough to call conclusive. The consistent signal in case-control studies, the physical presence of talc in ovarian tissue, and the WHO’s 2024 classification all point in the same direction. But the failure of prospective cohort studies to confirm the link, the lack of a dose-response pattern, and the unresolved question of asbestos contamination all prevent a definitive answer.
If you’ve used talcum powder in the genital area for years, the absolute increase in ovarian cancer risk, if it exists at all, is small. If you’d rather not take the chance, switching to cornstarch powder or skipping body powder entirely eliminates the question. Women who’ve never used perineal talc have no reason to worry about this particular risk factor.